Adaptive Biotechnologies Corp. (ADPT)
25.54
-0.45
(-1.73%)
USD |
NASDAQ |
Aug 24, 16:00
25.54
0.00 (0.00%)
After-Hours: 20:00
Adaptive Biotechnologies Total Liabilities (Quarterly) : 490.02M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 490.02M |
| March 31, 2026 | 281.70M |
| December 31, 2025 | 739.03M |
| September 30, 2025 | 286.36M |
| June 30, 2025 | 317.10M |
| March 31, 2025 | 320.63M |
| December 31, 2024 | 336.89M |
| September 30, 2024 | 334.93M |
| June 30, 2024 | 343.44M |
| March 31, 2024 | 345.56M |
| December 31, 2023 | 352.86M |
| September 30, 2023 | 356.04M |
| June 30, 2023 | 368.57M |
| March 31, 2023 | 367.51M |
| December 31, 2022 | 392.52M |
| Date | Value |
|---|---|
| September 30, 2022 | 396.39M |
| June 30, 2022 | 288.32M |
| March 31, 2022 | 304.94M |
| December 31, 2021 | 319.24M |
| September 30, 2021 | 341.06M |
| June 30, 2021 | 340.06M |
| March 31, 2021 | 346.38M |
| December 31, 2020 | 373.15M |
| September 30, 2020 | 320.43M |
| June 30, 2020 | 324.88M |
| March 31, 2020 | 323.32M |
| December 31, 2019 | 341.26M |
| September 30, 2019 | 331.47M |
| June 30, 2019 | 885.77M |
| March 31, 2019 | 888.05M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Personalis, Inc. | 76.97M |
| 10X Genomics, Inc. | 204.52M |
| Alamar Biosciences, Inc. (California) | 78.12M |
| Champions Oncology, Inc. | 22.92M |
| Medpace Holdings, Inc. | 1.623B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 640.68M |
| Shareholders Equity (Quarterly) | 142.91M |
| Debt to Equity Ratio | 2.872 |
| Current Ratio | 4.795 |
| Net Debt Paydown Yield | -1.11% |